Average Co-Inventor Count = 5.62
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alkermes Pharma Ireland Limited (13 from 160 patents)
2. Alkermes, Inc. (8 from 75 patents)
3. Amylin Pharmaceuticals, Inc. (3 from 164 patents)
4. Alkermes Controlled Therapeutics, Inc. (3 from 46 patents)
5. Alkermes Controlled Therapeutics, Inc. Ii (3 from 36 patents)
6. Other (1 from 832,680 patents)
7. Alkernnes Pharma Ireland Limited (1 from 1 patent)
8. Alkermes Controlled Therapeutics, Inc. I (1 from 1 patent)
30 patents:
1. 10328070 - Polymorphic forms of naltrexone
2. 10166228 - Polymorphic forms of naltrexone
3. 9980958 - Polymorphic forms of naltrexone
4. 9827240 - Polymorphic forms of naltrexone
5. 9556189 - Polymorphic forms of naltrexone
6. 9365580 - Polymorphic forms of naltrexone
7. 9238076 - Polymer-based sustained release device
8. 9221830 - Polymorphic forms of naltrexone
9. 8975272 - Polymorphic forms of naltrexone
10. 8877252 - Polymer-based sustained release device
11. 8735420 - Polymorphic forms of naltrexone
12. 8617613 - Polymer-based sustained release device
13. 8461105 - Polymer-based sustained release device
14. 8431685 - Polymer-based sustained release device
15. 8389540 - Polymorphic forms of naltrexone